GNPX
NASDAQ
$7.21
Genprex Inc (GNPX)
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company is headquartered in Austin, Texas.
Sector:
Healthcare
Industry:
Biotechnology
Target: $7.50 (+4.02%)
Market Cap
$4.44M
P/B Ratio
0.30
Price Chart
Valuation
Market Cap$4.44M
P/B0.30
Profitability
EBITDA-$16M
EPS-$12.48
Growth & Risk
EPS 5Y CAGR-17.83%
FCF 5Y CAGR-0.94%
Sharpe Ratio-0.59